YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and others. The company is headquartered in Yichang, Guangdong and currently employs 4,861 full-time employees. The firm's main products include Kewei (Oseltamivir Phosphate Capsules and Granules), Ertongshu (Benzbromarone Tablets), Oumeining (Telmisartan Tablets), Linluoxing (Moxifloxacin Hydrochloride Tablets) and Olmesartan Tablets and other products. The firm is also engaged in the centralized procurement business. The firm mainly conducts its business in the domestic market.
